Fact sheet: Pictet Biotech

Fund information

Fund name
Pictet Biotech I dy GBP
Fund company manager
Pictet Asset Management (Europ
Fund type
SIB
Fund manager(s)
Tazio Storni
since 26/05/2016
Lydia Haueter
since 26/05/2016
Fund objective
The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.
Benchmark
MSCI World
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

3.78 %

1 Year rank in sector

-

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.3 b

FE Risk score

224

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    91.4%
  • UK
    2.6%
  • Belgium
    1.6%
  • Denmark
    1%
  • Ireland
    0.9%
  • Health Care
    61.5%
  • Pharmaceuticals
    20.9%
  • Technology
    11.6%
  • Services
    5.1%
  • Money Market
    0.9%
  • US Equities
    91.4%
  • UK Equities
    2.6%
  • Belgian Equities
    1.6%
  • Danish Equities
    1%
  • Irish Equities
    0.9%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund-9.14 %0.7 %3.78 %26.65 %143.9 %
Sector-4.54 %0.79 %7.8 %12.47 %100.07 %
Rank within sector / / / / /
Quartile th th th th th th

Calendar performance

YTD-20172016201520142013
Fund11.12 %-8.61 %18.02 %31.77 %52.64 %
Sector11.8 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector / / / / /
Quartile th th th th th th

Risk statistics

Alpha3.79
Beta1.33
Sharpe0.24
Volatility22.86
Tracking error11.66
Information ratio0.36
R-Squared0.79

Price movement

52 week high659.11
52 week low513.17
Current bid price0
Current offer price0
Current mid price583

Holdings by region

  • 91.4% USA
  • 2.6% UK
  • 1.6% Belgium
  • 1% Denmark
  • 0.9% Ireland
  • 0.9% Money Market
  • 0.9% Switzerland
  • 0.7% Netherlands

Holdings by sector

  • 61.5% Health Care
  • 20.9% Pharmaceuticals
  • 11.6% Technology
  • 5.1% Services
  • 0.9% Money Market

Holdings by asset type

  • 91.4% US Equities
  • 2.6% UK Equities
  • 1.6% Belgian Equities
  • 1% Danish Equities
  • 0.9% Irish Equities
  • 0.9% Money Market
  • 0.9% Swiss Equities
  • 0.7% Dutch Equities

Individual holdings

  • 7% CELGENE CORP
  • 6.5% GILEAD SCIENCES INC
  • 6% BIOGEN INC
  • 5.9% AMGEN INC
  • 4.4% REGENERON PHARMACEUTICALS INC
  • 4.4% VERTEX PHARMACEUTICAL
  • 4.3% ALEXION PHARMACEUTICALS INC
  • 3.9% INCYTE CORP
  • 2.9% BIOMARIN PHARMACEUTICAL
  • 2.7% SEATTLE GENETICS INC